Clinical Trial Update: Romidepsin in Treating Patients With Recurrent and/or Metastatic Thyroid Cancer That Has Not Responded to Radioactive Iodine [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating romidepsin in patients with recurrent and/or metastatic thyroid cancer not responding to radioactive iodine; results were posted in 201…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Follicular Thyroid Cancer
• Papillary Thyroid Cancer
• Thyroid Cancer

Drugs mentioned

• Romidepsin (romidepsin)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Recurrent Thyroid Cancer, Stage IV Follicular Thyroid Cancer | Phase 2 | Status: COMPLETED | Results posted: 2013-12-19